Clinical Validation of the Management Process for Renal Anemia in Maintenance Hemodialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1296 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-14

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This test aims to verify that the management process of renal anemia in maintenance hemodialysis patients can improve the hemoglobin compliance rate better than that of anemia management by primary doctors, and promote the system at the grassroots level to guide primary doctors in anemia management and improve the management standard of renal anemia in maintenance hemodialysis patients through prospective randomized controlled trials. To improve the anemia compliance rate of maintenance hemodialysis patients, and to improve the basic doctors' grasp of the anemia management guidelines, consensus and standard operating procedures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of an Anemia Model Predictive Controller for Anemia Management in Hemodialysis Patients

NCT04360902

End Stage Renal Disease Renal Anemia Chronic Kidney Diseases

UNKNOWN NA

A Clinical Study on the Impact of Hemoperfusion on the Prognosis of Uremic Patients Undergoing Maintenance Hemodialysis

NCT06981559

Hemodialysis

NOT_YET_RECRUITING

A Retrospective Observational Study to Describe Anaemia Management, Burden of Disease and Outcomes in Chinese Patients on Peritoneal Dialysis Using a Clinical Database

NCT04948424

Anemia

COMPLETED

Routine and Deferred Dialysis Initiation

NCT02423655

Chronic Kidney Disease

UNKNOWN NA

Preliminary Exploration of Thromboelastography in the Monitoring of Anticoagulation in Maintenance Hemodialysis Patients

NCT06272708

Thromboelastography Hemodialysis Anticoagulation

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anemia of Chronic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Standardized guidance for anemia treatment by grassroots doctors using the maintenance hemodialysis renal anemia management process

Group Type EXPERIMENTAL

Guiding treatment

Intervention Type OTHER

Standardized guidance for anemia treatment by grassroots doctors using the maintenance hemodialysis renal anemia management process

control group

Experiential treatment by grassroots doctors

Group Type ACTIVE_COMPARATOR

empirical therapy

Intervention Type OTHER

Experiential treatment by grassroots doctors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Guiding treatment

Standardized guidance for anemia treatment by grassroots doctors using the maintenance hemodialysis renal anemia management process

Intervention Type OTHER

empirical therapy

Experiential treatment by grassroots doctors

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

① Age over 18 years old; ② Receive regular hemodialysis at least twice a week for at least 3 months, and have no plans to stop hemodialysis within 6 months since the start of the trial; ③ The patient voluntarily participated in this study.

Exclusion Criteria

* Patients who have planned to undergo kidney transplantation or terminate hemodialysis during the study period; ② Previous history of bone marrow hematopoietic system diseases, such as combined myelodysplastic syndrome, multiple myeloma, and other diseases; ③ Any known hereditary blood disease, such as thalassemia, sickle cell anemia, pure red blood cell aplasia, etc.; ④ Active or chronic gastrointestinal bleeding; ⑤ There was a severe infection within one week prior to screening.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No